Core Insights - Kimberly-Clark Corporation (NASDAQ:KMB) is viewed as potentially bottoming out, with a turnaround in progress as noted by Jim Cramer [1] - The company is recognized for its personal care and tissue products, including baby care, feminine care, incontinence, and household paper products [1] - CEO Michael Hsu is leading a restructuring effort that is currently underappreciated in the market [1] Company Overview - Kimberly-Clark manufactures and sells a variety of personal care and tissue products [1] - The company is described as being in the midst of a "terrific turnaround" [1] Market Position - Cramer highlights Kimberly-Clark as a company with a 4% yield, indicating its attractiveness for income-focused investors [1] - The company is compared to Procter & Gamble, which has already begun a similar turnaround process [1] Investment Perspective - While Kimberly-Clark shows potential, there are suggestions that certain AI stocks may offer greater upside potential and less downside risk [1]

Core Insights - Kimberly-Clark Corporation (NASDAQ:KMB) is recognized as one of the 10 Best Recession Proof Dividend Stocks to Buy [1] - The company is a global leader in consumer goods, particularly known for its personal care and tissue brands such as Huggies, Kotex, and Kleenex [2] - Demand for Kimberly-Clark's products remains stable during economic downturns, as essential items like diapers and toilet paper are necessary for households [3] Financial Resilience - During the 2007–09 financial crisis, Kimberly-Clark experienced only a 4% decline in sales, showcasing its resilience [4] - The company has effectively managed inflationary pressures on raw materials through price increases and efficiency measures [4] - Kimberly-Clark is classified as a Dividend King, having achieved 53 consecutive years of dividend growth, with a current quarterly dividend of $1.26 per share and a dividend yield of 4.12% as of September 26 [4]

Core Insights - Kimberly-Clark Corporation (NASDAQ:KMB) is recognized as one of the 10 Safest High Dividend Stocks to buy currently [1] - The company is known for its personal care and tissue products, with leading brands such as Huggies, Kotex, and Kleenex, serving both household and commercial markets globally [2] Business Strategy - In recent years, Kimberly-Clark has focused on product innovation and operational efficiency to enhance customer loyalty and market share [3] - The company has initiated a multi-year Transformation Initiative aimed at reducing costs and creating a more flexible operating structure, which is crucial for navigating supply chain complexities and external challenges like tariffs and rising costs [3] Dividend Performance - Kimberly-Clark has a strong dividend history, having raised its payouts for 53 consecutive years, currently offering a quarterly dividend of $1.26 per share [4] - The company boasts a dividend yield of 4.04% as of September 20, making it an attractive option for dividend-seeking investors [4]

Company Overview - Kimberly-Clark Corporation (KMB) has a market cap of $43.1 billion and is a leading consumer products company known for its personal care and tissue brands, operating in over 175 countries since its founding in 1872 [1][2] Business Model and Performance - The company is classified as a "large-cap" stock, focusing on essential consumer products, which contributes to its resilient business model. It is recognized as a dividend aristocrat, consistently returning capital to shareholders through dividends for decades [2] - Despite its strengths, KMB shares have retreated 13% from their 52-week high of $150.45 and have declined 1.3% over the past three months, underperforming the S&P 500 Index, which returned 8.4% in the same period [3][4] Stock Performance - Year-to-date, KMB stock is down marginally, underperforming the S&P 500's 10.7% rise, and has dipped 11% over the past 52 weeks compared to the S&P 500's 19% increase [4] - The stock has fallen below its 50-day and 200-day moving averages since early June, indicating a downtrend [4] Recent Earnings Report - On August 1, KMB shares rose 4.8% following the Q2 earnings report, which showed strong operational performance with exceptional volume gains and organic growth, particularly in North America. The adjusted EPS was $1.92, exceeding Wall Street expectations of $1.68, while revenue was $4.2 billion, down 1.6% year over year [5] Competitive Landscape - In comparison, rival Procter & Gamble (PG) has also faced challenges, with shares decreasing 9.4% over the past 52 weeks and 4.9% year-to-date. PG has a consensus rating of "Moderate Buy" from analysts, with a mean price target of $142.89, indicating a potential upswing of 9.1% from current prices [6]